Timothy W. Trost
Highly-accomplished Chief Financial Officer, having held the role with his 5 most recent emerging companies (public and VC-backed) in the life sciences space over the past 20-plus years. Has raised over $900 million in capital, comprised of approximately $700 million of venture capital and public company offering proceeds, and over $200 million of non-dilutive government funding, pharma sublicensing and collaboration proceeds, and other nontraditional financings. In addition to fundraising experience, has sourced, built and managed financial and accounting infrastructure ranging from small finance teams, to leading a 40-employee corporate finance group. Has similarly built high performance teams in related corporate functions including HR, IT and IR.
Currently serves as CFO of privately-held AskBio. Previous to Ask, served as CFO of Chimerix (NASDAQ: CMRX), where he took the company through its IPO and 4 follow-on financings. Prior to CMRX, was CFO of Argos Therapeutics, a VC-backed company where he was instrumental in venture financing, collaboration with a Japanese pharma, and sourcing capital via disposition of stock received in sublicensing transaction. Previous to Argos, served as CFO of InteCardia, a VC-backed entity where he coordinated 4 rounds of venture capital, consummation of 2 acquisitions, and the successful sale of the company to a NASDAQ-listed entity. Prior to InteCardia, was CFO of NYSE-listed Coastal Physician Group, after having joined as VP Corporate Development, where he was one of a 3-person leadership team over a 13-person M&A department.
Early career experience includes VP Finance of Morganite North America, the US holding company for Morgan Advanced Materials (LON: MGAM). Began his professional career with PricewaterhouseCoopers, assigned to four office locations (including an international assignment), last serving as a Senior Manager in the Research Triangle practice. Holds a degree in accounting from the University of Illinois at Urbana-Champaign and is a CPA.